# SELUTION 4 De Novo Small Vessel IDE Trial

> **NCT05946629** · NA · RECRUITING · sponsor: **M.A. Med Alliance S.A.** · enrollment: 960 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** PCI with SELUTION SLR DCB
- **DEVICE:** PCI with FDA approved "-limus" DES

## Key facts

- **NCT ID:** NCT05946629
- **Lead sponsor:** M.A. Med Alliance S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2027-06
- **Final completion:** 2031-06
- **Target enrollment:** 960 (ESTIMATED)
- **Last updated:** 2025-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946629, "SELUTION 4 De Novo Small Vessel IDE Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05946629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*